Skip to main content

Table 4 Bleeding events of In-Hospital and 12-Months Follow-Up

From: Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study

Variables

Ticagrelor 90 mg (n = 171)

Ticagrelor 60 mg (n = 178)

Clopidogrel 75 mg (n = 176)

P-value

Bleedings in hospital

Major bleeding, n(%)

2 (1.2%)

1 (0.6%)

1 (0.6%)

0.699

Minor bleeding, n(%)

31 (18.1%)

18 (10.1%)

16 (9.1%)

0.021

Bleedings during 12-month follow-up

Major bleeding, n(%)

7 (4.1%)

1 (0.6%)

1 (0.6%)

0.016

Minor bleeding, n(%)

40 (23.4)

22 (12.4%)

21 (11.9%)

0.004